Studies in vitro suggest FLCN has a role facilitating mTOR activation at the lysosome surface, however further studies are needed to clarify mechanisms involved in mTOR signalling by the FLCN/FNIP complex and possibly validate the role of mTOR inhibition in tumour progression suppression [12, 13]. This evidence concerns the gene FLCN and neoplasm.